Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses.

Gaziano, Liam; Sun, Luanluan; Arnold, Matthew; Bell, StevenORCID logo; Cho, Kelly; Kaptoge, Stephen K; Song, Rebecca J; Burgess, Stephen; Posner, Daniel CORCID logo; Mosconi, Katja; +104 more...Robinson-Cohen, Cassianne; Mason, Amy MORCID logo; Bolton, Thomas R; Tao, Ran; Allara, EliasORCID logo; Schubert, Petra; Chen, Lingyan; Staley, James R; Staplin, NatalieORCID logo; Altay, Servet; Amiano, Pilar; Arndt, VolkerORCID logo; Ärnlöv, JohanORCID logo; Barr, Elizabeth LMORCID logo; Björkelund, Cecilia; Boer, Jolanda MAORCID logo; Brenner, HermannORCID logo; Casiglia, EdoardoORCID logo; Chiodini, PaoloORCID logo; Cooper, Jackie A; Coresh, JosefORCID logo; Cushman, MaryORCID logo; Dankner, Rachel; Davidson, Karina WORCID logo; de Jongh, Renate TORCID logo; Donfrancesco, Chiara; Engström, GunnarORCID logo; Freisling, Heinz; de la Cámara, Agustín GómezORCID logo; Gudnason, VilmundurORCID logo; Hankey, Graeme JORCID logo; Hansson, Per-OlofORCID logo; Heath, Alicia KORCID logo; Hoorn, Ewout JORCID logo; Imano, HironoriORCID logo; Jassal, Simerjot K; Kaaks, Rudolf; Katzke, VerenaORCID logo; Kauhanen, Jussi; Kiechl, StefanORCID logo; Koenig, WolfgangORCID logo; Kronmal, Richard AORCID logo; Kyrø, CecilieORCID logo; Lawlor, Deborah A; Ljungberg, BörjeORCID logo; MacDonald, ConorORCID logo; Masala, GiovannaORCID logo; Meisinger, Christa; Melander, Olle; Moreno Iribas, Conchi; Ninomiya, ToshiharuORCID logo; Nitsch, DorotheaORCID logo; Nordestgaard, Børge GORCID logo; Onland-Moret, CharlotteORCID logo; Palmieri, LuigiORCID logo; Petrova, Dafina; Garcia, Jose Ramón Quirós; Rosengren, AnnikaORCID logo; Sacerdote, Carlotta; Sakurai, Masaru; Santiuste, Carmen; Schulze, Matthias BORCID logo; Sieri, SabinaORCID logo; Sundström, JohanORCID logo; Tikhonoff, ValérieORCID logo; Tjønneland, Anne; Tong, TammyORCID logo; Tumino, Rosario; Tzoulaki, IoannaORCID logo; van der Schouw, Yvonne TORCID logo; Monique Verschuren, WM; Völzke, Henry; Wallace, Robert B; Wannamethee, S GoyaORCID logo; Weiderpass, ElisabeteORCID logo; Willeit, PeterORCID logo; Woodward, MarkORCID logo; Yamagishi, KazumasaORCID logo; Zamora-Ros, RaulORCID logo; Akwo, Elvis A; Pyarajan, Saiju; Gagnon, David RORCID logo; Tsao, Philip SORCID logo; Muralidhar, Sumitra; Edwards, Todd LORCID logo; Damrauer, Scott MORCID logo; Joseph, JacobORCID logo; Pennells, LisaORCID logo; Wilson, Peter WF; Harrison, Seamus; Gaziano, Thomas AORCID logo; Inouye, Michael; Baigent, Colin; Casas, Juan P; Langenberg, ClaudiaORCID logo; Wareham, NickORCID logo; Riboli, Elio; Gaziano, J Michael; Danesh, John; Hung, Adriana MORCID logo; Butterworth, Adam SORCID logo; Wood, Angela M; Di Angelantonio, EmanueleORCID logo; and Emerging Risk Factors Collaboration/EPIC-CVD/Million Veteran Pro (2022) Mild-to-Moderate Kidney Dysfunction and Cardiovascular Disease: Observational and Mendelian Randomization Analyses. Circulation, 146 (20). pp. 1507-1517. ISSN 0009-7322 DOI: 10.1161/CIRCULATIONAHA.122.060700
Copy

BACKGROUND: End-stage renal disease is associated with a high risk of cardiovascular events. It is unknown, however, whether mild-to-moderate kidney dysfunction is causally related to coronary heart disease (CHD) and stroke. METHODS: Observational analyses were conducted using individual-level data from 4 population data sources (Emerging Risk Factors Collaboration, EPIC-CVD [European Prospective Investigation into Cancer and Nutrition-Cardiovascular Disease Study], Million Veteran Program, and UK Biobank), comprising 648 135 participants with no history of cardiovascular disease or diabetes at baseline, yielding 42 858 and 15 693 incident CHD and stroke events, respectively, during 6.8 million person-years of follow-up. Using a genetic risk score of 218 variants for estimated glomerular filtration rate (eGFR), we conducted Mendelian randomization analyses involving 413 718 participants (25 917 CHD and 8622 strokes) in EPIC-CVD, Million Veteran Program, and UK Biobank. RESULTS: There were U-shaped observational associations of creatinine-based eGFR with CHD and stroke, with higher risk in participants with eGFR values <60 or >105 mL·min-1·1.73 m-2, compared with those with eGFR between 60 and 105 mL·min-1·1.73 m-2. Mendelian randomization analyses for CHD showed an association among participants with eGFR <60 mL·min-1·1.73 m-2, with a 14% (95% CI, 3%-27%) higher CHD risk per 5 mL·min-1·1.73 m-2 lower genetically predicted eGFR, but not for those with eGFR >105 mL·min-1·1.73 m-2. Results were not materially different after adjustment for factors associated with the eGFR genetic risk score, such as lipoprotein(a), triglycerides, hemoglobin A1c, and blood pressure. Mendelian randomization results for stroke were nonsignificant but broadly similar to those for CHD. CONCLUSIONS: In people without manifest cardiovascular disease or diabetes, mild-to-moderate kidney dysfunction is causally related to risk of CHD, highlighting the potential value of preventive approaches that preserve and modulate kidney function.


picture_as_pdf
Gaziano-etal_2022_Mild-to-moderate-kidney-dysfunction.pdf
subject
Accepted Version
Available under Creative Commons: Attribution 4.0

View Download

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL Data Cite XML EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads